{Reference Type}: Journal Article
{Title}: Engineering Approaches for Exosome Cargo Loading and Targeted Delivery: Biological versus Chemical Perspectives.
{Author}: Ahmed W;Mushtaq A;Ali S;Khan N;Liang Y;Duan L;
{Journal}: ACS Biomater Sci Eng
{Volume}: 0
{Issue}: 0
{Year}: 2024 Jun 28
{Factor}: 5.395
{DOI}: 10.1021/acsbiomaterials.4c00856
{Abstract}: Exosomes are nanoscale membrane bound vesicles secreted by almost all types of cells. Their unique attributes, such as minimal immunogenicity and compatibility with biological systems, make them novel carriers for drug delivery. These native exosomes harbor proteins, nucleic acids, small molecule compounds, and fluorogenic agents. Moreover, through a combination of chemical and bioengineering methodologies, exosomes are tailored to transport precise therapeutic payloads to designated cells or tissues. In this review, we summarize the strategies for exosome modification and drug loading modalities in engineered exosomes. In addition, we provide an overview of the advances in the use of engineered exosomes for targeted drug delivery. Lastly, we discuss the merits and limitations of chemically engineered versus bioengineered exosome-mediated target therapies. These insights offer additional options for refining engineered exosomes in pharmaceutical development and hold promise for expediting the successful translation of engineered exosomes from the bench to the bedside.